Robert Driscoll

Director of Finance

Mr. Driscoll brings twenty years of finance expertise in both multi-national corporations and venture-backed life sciences firms to BioAdvance. His career has focused on financial management reporting and consolidation, budgeting and forecasting, treasury management, and internal financial controls.

Prior to joining BioAdvance Mr. Driscoll was controller with BioRexis Pharmaceutical Corporation (acquired by Pfizer Corporation). He also served as controller with Targeted Genetics Corporation (formerly Genovo, Inc.), and he held financial management positions with Nexell Therapeutics, Kulicke & Soffa Industries, Pfizer and ICI Americas. Mr. Driscoll holds a Masters of Science in financial management and a Bachelor of Science in accounting from Drexel University.